Skip to main content

$0.036 0.001 (2.86%)

High

$0.04

Low

$0.03

Trades

14

Turnover

$7,016

Volume

196,850
30 June 2023 at 3:58pm
Register to track SHG and receive email alerts.
Subject
SHG Ann: GeoVR JV to commercialise 3D & Virtual Reality software

SHG Ann: JobKeeper s323DB notice

SHG Ann: Quarterly Activities/Appendix 4C Cash Flow Report

SHG Ann: AGM Director Notice

SHG Ann: Letter to Shareholders

SHG Ann: Notice of Annual General Meeting/Proxy Form

SHG Ann: OSX: Osteopore collaborates with Singular Health Group

SHG Ann: CSIRO Collaboration for AI-based Tool

SHG Ann: Advisory Board appointment of Dr Bradley Moore

SHG Ann: Proposed issue of securities - SHG

SHG Ann: Appointment of Corporate Advisor

SHG Ann: Appendix 4G and Corporate Governance Statement

SHG Ann: Annual Report to shareholders

SHG Ann: Advisory Board appointment of Professor Jonathan Clark AM

SHG Ann: Appendix 4E - Preliminary Final Report 30 June 2021

SHG Ann: Launch of Mobile 3D Scan App For Patient Communication

SHG Ann: Application for quotation of securities - SHG

SHG Ann: Quarterly Activities/Appendix 4C Cash Flow Report

SHG Ann: Application for quotation of securities - SHG

SHG Ann: Restricted Securities to be Released from Escrow

SHG Ann: Restricted Securities to be Released from Escrow

SHG Ann: Application for quotation of securities - SHG

SHG Ann: Application for quotation of securities - SHG

SHG Ann: Application for quotation of securities - SHG

SHG Ann: Restricted Securities to be Released from Escrow

SHG Ann: Restricted Securities to be Released from Escrow

SHG Ann: Application for quotation of securities - SHG

SHG Ann: Application for quotation of securities - SHG

SHG Ann: SHG launches innovative Medical File Transfer Protocol

SHG Ann: Restricted Securities to be Released from Escrow

SHG Ann: Restricted Securities to be Released from Escrow

SHG Ann: Investor Presentation

SHG Ann: Appendix 2A - release of restricted securities from escrow

SHG Ann: Appendix 2A - release of restricted securities from escrow

SHG Ann: Appendix 2A

SHG Ann: Singular Health launches Scan to SurgeryTM initiative

SHG Ann: Restricted Securities to be Released from Escrow

SHG Ann: Restricted Securities to be Released from Escrow

SHG Ann: Appendix 2A - release of restricted securities from escrow

SHG Ann: Restricted Securities to be Released from Escrow

SHG Ann: Results of Meeting

SHG Ann: Quarterly Activities and Appendix 4C Cashflow Report

SHG Ann: 3D Medical Software Launch and FDA 510(K) Application

SHG Ann: Ceasing to be a substantial holder

SHG Ann: Appendix 2A - release of restricted securities from escrow

SHG Ann: Notice of Extraordinary General Meeting/Proxy Form

SHG Ann: Letter to Shareholders

SHG Ann: Restricted Securities to be Released from Escrow

SHG Ann: R&D Tax Incentive Refund Received

SHG Ann: CSIRO Artificial Intelligence Spinal Project Completion

Register to track SHG and receive email alerts.